Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada -EMMA-Can

NCT04923984 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT04923984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04923984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada -EMMA-Can
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2021
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma